申请人:NOVARTIS AG
公开号:US20130149281A1
公开(公告)日:2013-06-13
The present application describes a method of treating an HCV-associated disorder by administering to a subject in need thereof a pharmaceutically effective amount of a compound of formula I in combination with an additional HCV-modulating compound.